A detailed history of Eastern Bank transactions in Astrazeneca PLC stock. As of the latest transaction made, Eastern Bank holds 792 shares of AZN stock, worth $53,380. This represents 0.0% of its overall portfolio holdings.

Number of Shares
792
Holding current value
$53,380
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$76.67 - $87.62 $60,722 - $69,395
792 New
792 $61,000
Q1 2021

Apr 27, 2021

SELL
$47.16 - $54.44 $400,860 - $462,740
-8,500 Closed
0 $0
Q3 2020

Oct 30, 2020

SELL
$53.07 - $61.1 $169,824 - $195,520
-3,200 Reduced 27.35%
8,500 $466,000
Q3 2019

Nov 04, 2019

SELL
$40.12 - $45.47 $75,225 - $85,256
-1,875 Reduced 13.81%
11,700 $521,000
Q2 2019

Jul 24, 2019

BUY
$37.28 - $41.68 $69,900 - $78,150
1,875 Added 16.03%
13,575 $560,000
Q3 2017

Oct 24, 2017

BUY
$28.96 - $34.0 $338,832 - $397,800
11,700
11,700 $396,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $209B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Eastern Bank Portfolio

Follow Eastern Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.